CFD 属于复杂的高风险金融工具,其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作,以及是否能够接受高额亏损的风险。

Scan to Download iOS&Android APP

交易 Organovo Holdings, Inc. - ONVO CFD

2.24
3.23%
  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 0.06
多头隔夜费

Long position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.024068%
空头隔夜费

Short position overnight fee


Margin. Your investment $1,000.00
隔夜费用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
0.001846%
隔夜费时间 21:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

关键数据
前收盘价* 2.17
开盘价* 2.12
1 年变化* -41.27%
日范围* 2.05 - 2.24
52 周范围 1.37-3.94
平均交易量(10 天) 38.33K
平均交易量(3 个月) 2.52M
市值 19.78M
市盈率 -100.00K
流通股 8.71M
收入 1.71M
EPS -1.34
股息(收益率 %) N/A
贝塔 0.90
下一个财报发布日期 N/A

所有数据都是由Refinitiv提供的, 除了标有星号的数据, 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low
Mar 28, 2023 2.17 -0.07 -3.13% 2.24 2.30 2.12
Mar 27, 2023 2.22 0.19 9.36% 2.03 2.27 2.00
Mar 24, 2023 1.98 0.07 3.66% 1.91 1.98 1.91
Mar 23, 2023 1.93 -0.10 -4.93% 2.03 2.06 1.91
Mar 22, 2023 1.99 0.06 3.11% 1.93 2.03 1.91
Mar 21, 2023 1.91 0.03 1.60% 1.88 1.96 1.88
Mar 20, 2023 1.88 -0.08 -4.08% 1.96 1.97 1.84
Mar 17, 2023 1.93 0.04 2.12% 1.89 1.97 1.88
Mar 16, 2023 1.94 0.05 2.65% 1.89 1.98 1.88
Mar 15, 2023 1.89 0.01 0.53% 1.88 1.93 1.87
Mar 14, 2023 1.94 0.05 2.65% 1.89 1.99 1.85
Mar 13, 2023 1.87 0.14 8.09% 1.73 1.94 1.71
Mar 10, 2023 1.78 -0.08 -4.30% 1.86 1.86 1.74
Mar 9, 2023 1.85 -0.18 -8.87% 2.03 2.04 1.83
Mar 8, 2023 2.05 -0.07 -3.30% 2.12 2.12 2.02
Mar 7, 2023 2.10 -0.08 -3.67% 2.18 2.19 2.03
Mar 6, 2023 2.21 0.03 1.38% 2.18 2.23 2.17
Mar 3, 2023 2.14 -0.07 -3.17% 2.21 2.25 2.06
Mar 2, 2023 2.19 -0.02 -0.90% 2.21 2.21 2.08
Mar 1, 2023 2.14 -0.16 -6.96% 2.30 2.31 2.11

Organovo Holdings, Inc. Events

時間(協調世界時) (UTC) 國家 事件
No events scheduled
查看所有活動
  • 年度
  • 每季度
2022 2021 2020 2019 2018
总收入 1.5 0 2.196 3.091 4.603
收入 1.5 0 2.196 3.091 4.603
收入成本,共计 0 0.328 0.482 1.03
毛利 0 1.868 2.609 3.573
总营业费用 12.979 16.826 23.671 30.365 39.874
销售/一般/行政费用,总计 9.631 12.9 14.423 15.131 20.888
研究与开发 3.206 1.077 5.051 14.752 17.956
营业收入 -11.479 -16.826 -21.475 -27.274 -35.271
利息收入(费用),非经营净值 0.008 0.015 0.594 0.705 0.478
Gain (Loss) on Sale of Assets 0 -0.019 0.113 -0.063 0.004
税前净收入 -11.446 -16.824 -18.708 -26.632 -34.801
税后净收入 -11.448 -16.826 -18.71 -26.635 -34.803
未计算非常项目前的净收益 -11.448 -16.826 -18.71 -26.635 -34.803
净收入 -11.448 -16.826 -18.71 -26.635 -34.803
普通股股东可获收益 (不含非经常性项目) -11.448 -16.826 -18.71 -26.635 -34.803
普通股股东可获收益 (含非經常性項目) -11.448 -16.826 -18.71 -26.635 -34.803
摊薄净收入 -11.448 -16.826 -18.71 -26.635 -34.803
摊薄后加权平均股 8.7036 6.902 6.47781 5.769 5.3622
扣除特别项目的每股摊薄盈利 -1.31532 -2.43784 -2.88832 -4.61692 -6.49043
每股正常摊薄盈利 -1.31532 -2.17161 -2.62603 -4.60982 -6.49092
其他,净值 0.025 0.006 2.06 0 -0.012
非常规项目总计 0
Depreciation / Amortization 0.142 0.041 1.142
异常费用(收入) 0 2.808 2.727
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
总收入 1.5 0 0 0 0
收入 1.5 0
收入成本,共计 0
毛利 0
总营业费用 3.413 3.5 3.507 2.559 2.598
销售/一般/行政费用,总计 2.265 2.569 2.823 1.975 1.921
研究与开发 1.102 0.894 0.649 0.56 0.655
Depreciation / Amortization 0.046 0.037 0.035 0.024 0.022
异常费用(收入) 0 0
营业收入 -1.913 -3.5 -3.507 -2.559 -2.598
利息收入(费用),非经营净值 0.002 0.002 0.002 0.002 0.002
Gain (Loss) on Sale of Assets 0 0 0 0 0
其他,净值 0 0 0 0.025 0
税前净收入 -1.911 -3.498 -3.505 -2.532 -2.596
税后净收入 -1.911 -3.5 -3.505 -2.532 -2.596
未计算非常项目前的净收益 -1.911 -3.5 -3.505 -2.532 -2.596
净收入 -1.911 -3.5 -3.505 -2.532 -2.596
普通股股东可获收益 (不含非经常性项目) -1.911 -3.5 -3.505 -2.532 -2.596
普通股股东可获收益 (含非經常性項目) -1.911 -3.5 -3.505 -2.532 -2.596
摊薄净收入 -1.911 -3.5 -3.505 -2.532 -2.596
摊薄后加权平均股 8.70551 8.7055 8.70533 8.69668 7.65275
扣除特别项目的每股摊薄盈利 -0.21952 -0.40204 -0.40263 -0.29115 -0.33922
每股正常摊薄盈利 -0.21952 -0.40204 -0.40263 -0.29115 -0.33922
Dividends per Share - Common Stock Primary Issue 0 0 0
  • 年度
  • 每季度
2022 2021 2020 2019 2018
流动资产总额 29.533 38.398 28.318 38.574 46.76
现金和短期投资 28.675 37.364 27.356 36.477 43.726
现金等价物 28.675 37.364 27.356 36.477 43.726
应收账款总额,净额 0 0.111 0.558 1.028
Accounts Receivable - Trade, Net 0 0.111 0.503 0.883
Total Inventory 0 0.49 0.842
Prepaid Expenses 0.858 1.034 0.851 1.049 1.164
Total Assets 33.296 39.917 28.441 40.623 49.827
Property/Plant/Equipment, Total - Net 2.815 0.381 0 1.832 2.788
Property/Plant/Equipment, Total - Gross 3.886 1.383 0.415 6.413 6.856
Accumulated Depreciation, Total -1.071 -1.002 -0.415 -4.581 -4.068
Intangibles, Net 0.094 0.109 0.123 0.137 0.151
Other Long Term Assets, Total 0.854 1.029 0 0.08 0.128
Total Current Liabilities 1.383 0.721 1.81 3.737 4.658
Accounts Payable 0.415 0.281 0.72 0.628 0.464
Accrued Expenses 0.968 0.44 1.09 2.584 3.526
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 0 0.525 0.668
Total Liabilities 3.087 0.721 1.81 4.325 5.241
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 1.704 0 0.588 0.583
Total Equity 30.209 39.196 26.631 36.298 44.586
Common Stock 0.009 0.009 0.131 0.124 0.111
Additional Paid-In Capital 337.94 335.479 305.965 296.929 278.595
Retained Earnings (Accumulated Deficit) -307.739 -296.291 -279.465 -260.755 -234.12
Other Equity, Total 0
Total Liabilities & Shareholders’ Equity 33.296 39.917 28.441 40.623 49.827
Total Common Shares Outstanding 8.71063 8.67049 6.52791 6.20077 5.55165
Treasury Stock - Common -0.001 -0.001
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流动资产总额 29.533 31.171 34.303 36.658 38.398
现金和短期投资 28.675 30.269 33.791 36.008 37.364
现金等价物 28.675 30.269 33.791 36.008 37.364
应收账款总额,净额 0
Accounts Receivable - Trade, Net 0
Prepaid Expenses 0.858 0.902 0.512 0.65 1.034
Total Assets 33.296 35.095 35.881 38.294 39.917
Property/Plant/Equipment, Total - Net 2.815 2.921 0.552 0.554 0.381
Other Long Term Assets, Total 0.948 1.003 1.026 1.082 1.138
Total Current Liabilities 1.383 2.006 1.675 0.964 0.721
Accounts Payable 0.415 0.605 0.958 0.577 0.281
Accrued Expenses 0.968 1.401 0.717 0.387 0.44
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 3.087 3.802 1.675 0.964 0.721
Total Long Term Debt 0 0 0 0 0
Total Equity 30.209 31.293 34.206 37.33 39.196
Common Stock 0.009 0.009 0.009 0.009 0.009
Additional Paid-In Capital 337.94 337.113 336.526 336.145 335.479
Retained Earnings (Accumulated Deficit) -307.739 -305.828 -302.328 -298.823 -296.291
Treasury Stock - Common -0.001 -0.001 -0.001 -0.001 -0.001
Total Liabilities & Shareholders’ Equity 33.296 35.095 35.881 38.294 39.917
Total Common Shares Outstanding 8.71063 8.70555 8.70545 8.69813 8.67049
Other Liabilities, Total 1.704 1.796
  • 年度
  • 每季度
2022 2021 2020 2019 2018
净收入/起跑线 -11.448 -16.826 -18.71 -26.635 -34.803
经营活动产生的现金 -8.453 -13.323 -14.882 -20.375 -28.857
经营活动产生的现金 0.142 0.041 1.142 0.98 1.267
非现金物品 2.256 5.575 3.684 5.13 6.767
Cash Taxes Paid 0.002 -0.002 -0.002 -0.003 0.002
营运资金的变化 0.597 -2.113 -0.998 0.15 -2.088
投资活动产生的现金 -0.409 -0.393 0.747 -0.076 -0.292
资本支出 -0.409 -0.405 0 -0.079 -0.296
其他投资现金流量项目,总计 0 0.012 0.747 0.003 0.004
融资活动产生的现金 0.205 23.835 4.935 13.154 10.113
股票的发行(报废),净额 0.251 23.839 4.996 13.377 10.113
债务的发行(退还),净额 0
外汇效应 0 0.011
现金净变化 -8.657 10.119 -9.2 -7.297 -19.025
融资现金流项目 -0.046 -0.004 -0.061 -0.223
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -11.448 -9.537 -6.037 -2.532 -16.826
Cash From Operating Activities -8.453 -6.912 -3.556 -1.413 -13.323
Cash From Operating Activities 0.142 0.096 0.059 0.025 0.041
Non-Cash Items 2.256 1.429 0.841 0.415 5.575
Cash Taxes Paid 0.002 0.002 0 0 -0.002
Changes in Working Capital 0.597 1.1 1.581 0.679 -2.113
Cash From Investing Activities -0.409 -0.356 -0.223 -0.194 -0.393
Capital Expenditures -0.409 -0.356 -0.223 -0.194 -0.405
Other Investing Cash Flow Items, Total 0 0 0 0 0.012
Cash From Financing Activities 0.205 0.205 0.206 0.251 23.835
Financing Cash Flow Items -0.046 -0.046 -0.045 0 -0.004
Issuance (Retirement) of Stock, Net 0.251 0.251 0.251 0.251 23.839
Net Change in Cash -8.657 -7.063 -3.573 -1.356 10.119
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
Nikko Asset Management Co., Ltd. Investment Advisor/Hedge Fund 5.2183 454752 -6624 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.25 283225 151 2022-12-31 LOW
ARK Investment Management LLC Investment Advisor 2.4591 214302 -60565 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 1.691 147360 -185 2022-12-31 LOW
Renaissance Technologies LLC Hedge Fund 1.2859 112057 -7830 2022-12-31 HIGH
Murphy (Keith E) Individual Investor 1.0721 93427 19607 2022-11-10
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.7418 64641 -151 2022-12-31 LOW
Susquehanna International Group, LLP Investment Advisor 0.5815 50672 369 2022-12-31 MED
Cohen (Douglas Jay) Individual Investor 0.3627 31607 19607 2022-11-10 HIGH
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.3194 27831 0 2022-12-31 LOW
Morgan Stanley & Co. LLC Research Firm 0.3111 27113 10 2022-12-31 MED
Stern (Adam K.) Individual Investor 0.225 19607 19607 2022-11-10 HIGH
Joshi (Vaidehi) Individual Investor 0.225 19607 19607 2022-11-10
Milhous (Alison Tjosvold) Individual Investor 0.225 19607 19607 2022-11-10
Gobel (David) Individual Investor 0.225 19607 19607 2022-11-10 HIGH
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.1659 14461 0 2022-12-31 LOW
Morgan Stanley Smith Barney LLC Investment Advisor 0.0753 6559 -182 2022-12-31 LOW
CGM-AZIMUT MONACO Investment Advisor 0.0631 5500 0 2023-01-31 MED
UBS Financial Services, Inc. Investment Advisor 0.0482 4202 -2041 2022-12-31 LOW
Advisor Group, Inc Investment Advisor 0.0319 2783 -224 2022-12-31 LOW

为什么选择 Capital.com?让我们的数字来说话。

Capital.com Group

500K+

交易者

92K+

每月活跃客户

$53M+

每月投资额

$30M+

每月提取金额

交易計算器

如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。

貿易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模(槓桿 x 投資):
開倉

平倉

做空 做多

Organovo Holdings, Inc. Company profile

关于 Organovo Holdings Inc.

Organovo Holdings, Inc.是一家处于早期阶段的生物技术公司。 该公司专注于建立高保真的三维(3D)组织,再现人类疾病的关键方面。 公司以肠道为目标,正在进行溃疡性结肠炎(UC)和克罗恩病(CD)的三维组织开发。 公司利用其平台技术建立功能性三维人体组织,模仿本地人体组织成分、结构、功能和疾病的关键方面。 其NovoGen生物打印机是自动化设备,可以制造由哺乳动物细胞组成的三维活体组织。 NovoGen生物打印机可以分配纯水凝胶配方,也是公司组织原型和制造平台的重要组成部分。 公司还打算利用其生物打印平台以及三维技术来治疗其目标疾病。

Industry: Biotechnology & Medical Research (NEC)

Suite 110
6275 Nancy Ridge Drive
92121

收入报表

  • Annual
  • Quarterly

人们也观看

Oil - Crude

73.09 Price
-0.730% 1D Chg, %
多头隔夜费 -0.0162%
空头隔夜费 -0.0057%
隔夜费时间 21:00 (UTC)
价差 0.03

US100

12,823.80 Price
+1.550% 1D Chg, %
多头隔夜费 -0.0241%
空头隔夜费 0.0018%
隔夜费时间 21:00 (UTC)
价差 1.8

Gold

1,961.93 Price
-0.610% 1D Chg, %
多头隔夜费 -0.0087%
空头隔夜费 0.0005%
隔夜费时间 21:00 (UTC)
价差 0.30

XRP/USD

0.54 Price
+2.850% 1D Chg, %
多头隔夜费 -0.0753%
空头隔夜费 0.0069%
隔夜费时间 21:00 (UTC)
价差 0.00428

还在找一位您可以信任的经纪商吗?

加入成为全球500,000万多名交易者的一份子,选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易